• Open Daily: 10am - 10pm
    Alley-side Pickup: 10am - 7pm

    3038 Hennepin Ave Minneapolis, MN
    612-822-4611

Open Daily: 10am - 10pm | Alley-side Pickup: 10am - 7pm
3038 Hennepin Ave Minneapolis, MN
612-822-4611
Endocannabinoid Regulation of Monoamines in Psychiatric and Neurological Disorders

Endocannabinoid Regulation of Monoamines in Psychiatric and Neurological Disorders

Hardcover

Medical Reference

ISBN10: 1461479398
ISBN13: 9781461479390
Publisher: Springer Nature
Published: Jul 7 2013
Pages: 337
Weight: 1.38
Height: 0.93 Width: 6.33 Depth: 9.49
Language: English
The past decade has seen tremendous growth in the study of cannabinoid receptor signaling in brain. The impact and consequences of cannabinoid modulation of monoaminergic (dopamine, norepinephrine, and serotonin) circuits is becoming more clear. Scientists have shown significant interaction between these two systems in a variety of psychiatric and neurological disorders such as affective disorders, multiple sclerosis, and pain or pain disorders. The overarching goal of Endocannabinoid Regulation of Monoamines in Psychiatric and Neurological Disorders is to provide current information on advances in the field of endocannabinoid signaling and potential therapeutic applications with a particular emphasis on monoaminergic circuits. ​

1 different editions

Also available

Also in

Medical Reference